Lurasidone vs. Other Antipsychotics as Augmentation Strategies for Clozapine in Treatment-resistant Schizophrenia: An Observational Multicenter Prospective Study.

Prodi T, Benatti B, Grecchi A, Oresti M, Mazzoni F, Carnevale Miacca G, Brondino N, Dell'Osso B, Olivola M

Open source

DOI
10.2174/011570159x399781250910115949
Published
2026
Container
Current neuropharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/011570159x399781250910115949,
  title = {Lurasidone vs. Other Antipsychotics as Augmentation Strategies for Clozapine in Treatment-resistant Schizophrenia: An Observational Multicenter Prospective Study.},
  author = {Prodi T and Benatti B and Grecchi A and Oresti M and Mazzoni F and Carnevale Miacca G and Brondino N and Dell'Osso B and Olivola M},
  year = {2026},
  journal = {Current neuropharmacology},
  doi = {10.2174/011570159x399781250910115949},
  url = {https://doi.org/10.2174/011570159x399781250910115949}
}

RIS

TY  - JOUR
TI  - Lurasidone vs. Other Antipsychotics as Augmentation Strategies for Clozapine in Treatment-resistant Schizophrenia: An Observational Multicenter Prospective Study.
AU  - Prodi T
AU  - Benatti B
AU  - Grecchi A
AU  - Oresti M
AU  - Mazzoni F
AU  - Carnevale Miacca G
AU  - Brondino N
AU  - Dell'Osso B
AU  - Olivola M
PY  - 2026
JO  - Current neuropharmacology
DO  - 10.2174/011570159x399781250910115949
UR  - https://doi.org/10.2174/011570159x399781250910115949
ER  - 

APA

T, P., B, B., A, G., M, O., F, M., G, C. M., N, B., B, D., & M, O. (2026). Lurasidone vs. Other Antipsychotics as Augmentation Strategies for Clozapine in Treatment-resistant Schizophrenia: An Observational Multicenter Prospective Study.. Current neuropharmacology. https://doi.org/10.2174/011570159x399781250910115949

Source records